Rhumbline Advisers Axogen, Inc. Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
A detailed history of Rhumbline Advisers transactions in Axogen, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 56,711 shares of AXGN stock, worth $922,120. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,711
Previous 58,157
2.49%
Holding current value
$922,120
Previous $421,000
88.84%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding AXGN
# of Institutions
162Shares Held
36.6MCall Options Held
230KPut Options Held
400-
First Light Asset Management, LLC Edina, MN4.09MShares$66.5 Million5.0% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$52.8 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.01MShares$48.9 Million3.58% of portfolio
-
Morgan Stanley New York, NY2.9MShares$47.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$39.4 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $688M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...